Introduction
The rising demand for drug testing comes from pressure from society to stem the spread of substance abuse and to provide people with greater protection. In response to this demand, urinalysis testing programmes have been implemented by a variety of organizations, such as business and industrial employers, the transportation industry," police and fire departments, the military, and sports [1] [2] [3] [4] [5] [6] [7] . The drugs most commonly tested for are marijuana, cocaine, amphetamines and narcotic analgesics. Some programmes also test for benzodiazepines, barbiturates and phencyclidine.
A common denominator is the widely accepted notion that drug testing will identify the primary offenders. The extent to which this objective is achieved is most appropriately addressed by specialists in behavioural medicine and sociology. The scientific basis for urinalysis programmes is in the domain of clinical and analytical chemistry.
The analysis of body fluids for drugs takes place in two distinctly different environments: the medical model and the penalty model. In the former, and in the context of patient care, the physician requests the test and the patient is both fully co-operative with the sample collectors and highly motivated to provide the ideal sample. In the latter case, the request usually comes from a non-medical authority and it may not be in the best interest of the individual to submit a valid sample. In the medical model the information obtained from the test is used to assist the physician in the care and management of the patient. In contrast, in the penalty model the results are used to impose some penalty to the individual. This fundamental difference, together with legal imperatives, has broad implications for the overall design and implementation of a drug testing programme.
Although it may seem counter-intuitive, testing in the penalty model is far more demanding and difficult than with the medical model. For example, ifa physician sends a sample from an unconscious patient to the laboratory for a rapid screen, and, one hour later, the report is positive for opiates by immunoassay the physician will use this information to [1, 9] . Some banned substances are also produced endogenously (for example testosterone), and in the case of several substances the ban is based on quantification. Detection of the administration of exogenous testosterone requires special testing techniques [8, 10, 11] . For the additional protection of the testee, many organizations require the division of the urine sample into two parts, A and B, to be sealed individually. The laboratory ordinarily receives both, saves the B intact, analyses the A, and reports the results to the organization.
Chain of custody
To ensure that the urine tested suffered no contamination, tampering, or mislabelling, the chain of custody begins at the collection site and ends with the final report. The sample is handled at first only by the testee until sealed, then by collection site officials, transportation personnel, and laboratory technicians. The control system must guarantee integrity of the specimens from the moment of submission of the urine until the conclusion of the analysis. Each transfer must be documented, including within-laboratory transfers. [20, 21] . [22] .
The concentration in urine may also be estimated if clearance of drug and water are known. If the drug is orally administered the model must include bioavailability and the rate of absorption. Sophisticated pharmacokinetic models can also account for multiple and variable doses and dosage intervals [22, 23] . Drugs with long half-lives and/or large volumes of distribution may be detectable in small amounts in urine for months.
Examples of studies which provide useful pharmacokinetic data are: marijuana [24] [25] [26] , cocaine [23, 27] , amphetamine [28] . Reviews [3, 6, 8] Many of the relevant variables are rarely known, therefore the interpreter evaluates the pattern of excretion of drug and metabolites as determined by clinical studies. One must consider the sensitivity of the assays since it is a major determinant of detection times. Clearly a large dose will result in a positive test for a longer time than a small dose. Multiple closely spaced doses will result in drug accumulation, an increase in total body burden, and longer detection times. For example urine collected within the first few hours after cocaine administration contains both cocaine and benzoylecgonine, while urine collected a several hours later will not contain detectable amounts of cocaine [27] . The principal metabolite of tetrahydrocannabinol (ll-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid) is usually detectable for one or two days after single exposure, however multiple exposures may lead to a positive test for two or more weeks after cessation [25] . In addition passive exposure to marijuana smoke may result in sufficient absorption to result in detectable amounts of marijuana metabolites in urine [29] . [30] . Since morphine is a major metabolite of heroin, the detection of morphine is compatible with administration of heroin or the ingestion of poppy-seed products. One way to clarify this situation is to analyse the urine for 6-monoacetylmorphine, which is a metabolite of heroin and not a metabolite of morphine, and not found in poppy seeds [31] .
Drug interactions
The best studied drug interactions known to markedly influence drug or A number of clinically significant drug interactions resulting from concomitant administration of cimetidine with drugs such as caffeine, beta-blockers, barbiturates, morphine, and ethanol have been described [32] . The mechanism of inhibition is an interaction of cimetidine with the heme iron in cytochrome P450 [33] . Like cimetidine, the anabolic steroid stanozolol interacts with cytochrome P450 and is a potent inhibitor of cytochrome P450-catalysed reactions [34] . Depending of the particular isoenzymes of that are inhibited stanozolol could alter the elimination of other anabolic steroids.
Interactions involving drugs that influence the pH and water metabolism of the body alter the excretion rates of many banned drugs. The urinary excretion of many drugs is markedly influenced by urine pH [22, 28, 35, 36] . 
